Dosimetric comparison of Gamma Knife® Icon^TM and linear accelerator-based fractionated stereotactic radiotherapy (FSRT) plans for the re-irradiation of large (>14 cm³) recurrent glioblastomas.

IF 0.7 Q4 SURGERY

Journal of radiosurgery and SBRT Pub Date : 2021-01-01

Matthew E Schelin, Haisong Liu, Ayesha Ali, Wenyin Shi, Yan Yu, Karen E Mooney

{"title":"Dosimetric comparison of Gamma Knife® IconTM and linear accelerator-based fractionated stereotactic radiotherapy (FSRT) plans for the re-irradiation of large (>14 cm3) recurrent glioblastomas.","authors":"Matthew E Schelin, Haisong Liu, Ayesha Ali, Wenyin Shi, Yan Yu, Karen E Mooney","doi":"","DOIUrl":null,"url":null,"abstract":"Our objective is to investigate dosimetric differences between clinically deliverable Gamma Knife® (GK) Icon™ and linac-based FSRT plans on the basis of normal brain dose sparing for large (>14 cm3) recurrent glioblastomas (GBM). Sixteen patients with large, recurrent GBM were treated using re-irradiation via linac-based FSRT, 35 Gy in 10 fractions. For each patient, a new GK FSRT plan was created in Leksell GammaPlan® V11 (LGP). To maintain clinical deliverability, the LGP optimization included a planning goal of treatment time <20 minutes per fraction. Dosimetric comparison of coverage and normal brain dose between the linac and GK treatment plans was performed in MIM. The GK FSRT plans had significantly (p < 0.05) lower mean normal brain dose values (-8.85%), mean values of normal brain V20 (-32.4%) and V12 (-25.9%), and a lower mean V4 (-10.0%). GK FSRT plans have the potential to reduce the risk of radiation-related toxicities.","PeriodicalId":16917,"journal":{"name":"Journal of radiosurgery and SBRT","volume":"7 3","pages":"233-243"},"PeriodicalIF":0.7000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055238/pdf/rsbrt-7-243.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of radiosurgery and SBRT","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Our objective is to investigate dosimetric differences between clinically deliverable Gamma Knife^® (GK) Icon™ and linac-based FSRT plans on the basis of normal brain dose sparing for large (>14 cm³) recurrent glioblastomas (GBM). Sixteen patients with large, recurrent GBM were treated using re-irradiation via linac-based FSRT, 35 Gy in 10 fractions. For each patient, a new GK FSRT plan was created in Leksell GammaPlan^® V11 (LGP). To maintain clinical deliverability, the LGP optimization included a planning goal of treatment time <20 minutes per fraction. Dosimetric comparison of coverage and normal brain dose between the linac and GK treatment plans was performed in MIM. The GK FSRT plans had significantly (p < 0.05) lower mean normal brain dose values (-8.85%), mean values of normal brain V20 (-32.4%) and V12 (-25.9%), and a lower mean V4 (-10.0%). GK FSRT plans have the potential to reduce the risk of radiation-related toxicities.

本刊更多论文

伽玛刀®IconTM和基于线性加速器的分割立体定向放疗(FSRT)计划对大(>14 cm3)复发性胶质母细胞瘤再照射的剂量学比较

我们的目的是研究临床可交付的伽玛刀(GK) Icon™和基于linac的FSRT计划在正常脑剂量节约的基础上对大(>14 cm3)复发性胶质母细胞瘤(GBM)的剂量差异。16例复发性大GBM患者采用基于linacs的FSRT再照射治疗，每次35 Gy，分10次。对于每位患者，在Leksell GammaPlan®V11 (LGP)中创建了新的GK FSRT计划。为了保持临床可交付性，LGP优化包括治疗时间的计划目标

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of radiosurgery and SBRT SURGERY-

CiteScore

1.40

自引率

8.30%

发文量